Peptide Based Metabolic Disorders Therapeutics Report

By www.reportprimer.com

Report Details

Report Name

Global Peptide Based Metabolic Disorders Therapeutics Market Insights And Forecast To 2031 Story

Pages

93

Price

$ 4900

Features

Peptide Based Metabolic Disorders Therapeutics Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              AstraZeneca
Ingro Finanz (Bachem)
Eli Lilly
Ipsen
Merck
Novo Nordisk
PolyPeptide Group
Teva Pharmaceutical